Lakeland PeptidesPeptide therapy, explained · Lakeland & Polk County, FL

Goal

Peptides for Skin and Hair: What Lakeland Readers Should Know

Not reviewed by a licensed provider. Read our disclaimer

Last updated

Peptides show up in many skin and hair products, and some clinics now offer peptide injections for skin. This page explains which peptides are involved, what research shows and what to ask. It is general information, not advice for your situation.

Overview

The peptide most people meet first is GHK-Cu, the “copper peptide” in many serums and creams. Other peptides are promoted for wound healing, inflammation or tanning.

It helps to separate two kinds of products. Creams and serums are mostly sold as cosmetics. Injections are a different matter: they put a substance directly into the body, and for most of these peptides they have never been tested in people.

None of the peptides on this page is FDA-approved for skin or hair. Lab and animal studies are plentiful, but human studies are few and small.

Peptides used for skin and hair

  • GHK-Cu (very limited human data). A small copper-binding peptide the body makes. It is widely used in skin and hair products.1 In a randomized trial of 13 patients after laser skin resurfacing, GHK-Cu products did not improve measured redness, wrinkles or skin quality, though users rated their skin as better.2 A GHK-Cu wound gel looked promising for diabetic foot ulcers in a published early trial.3 Trade press in 1994 reported that a later trial was negative; full results were not published.4
  • LL-37 (very limited human data). An infection-fighting peptide the body makes in skin. In a 34-person trial on leg ulcers, only the lowest concentration was linked to faster healing-rate measures over 4 weeks; higher ones were not.5 A 148-person follow-up trial found no overall benefit over placebo.6
  • KPV (animal and lab data only). A three-amino-acid piece of a natural hormone. It calmed inflammation in cell and mouse studies, but FDA found no studies of KPV in people. In a lab test, it did not pass through intact human skin, which raises doubts about creams.7
  • Melanotan II (very limited human data). A lab-made copy of a skin-darkening hormone, sold online as “tanning” injections or nasal sprays. It has never been FDA-approved, and FDA has called it an unapproved new drug.8
  • TB-500 (animal and lab data only). Promoted for skin and wound healing. FDA found no study of TB-500 in humans, and in a lab test it did not speed wound closure in skin cells.9

What to realistically expect

  • Cream results are modest at best. The most-quoted GHK-Cu “clinical studies” were short conference abstracts that never appeared as full papers.10 The best-controlled published trial showed no measured difference from a regular cream.2
  • “Resets your genes” is not a skin result. That claim comes from computer analyses of gene data by researchers tied to the peptide, not from studies of people’s skin.1
  • Hair growth is unproven. The research behind this site did not review hair-growth trials of GHK-Cu or other peptides. A dermatologist can explain options with stronger evidence.
  • More is not always better. Too much LL-37 in skin is linked to the inflammation seen in rosacea.11
  • Regulatory news is not approval. An FDA advisory committee narrowly voted in July 2026 to recommend allowing pharmacies to compound KPV. FDA’s own reviewers had recommended against it, and the vote is not binding. It was reported as 8 to 6 with 1 abstention.12 As of November 13, 2026, HHS has published a draft, non-binding policy saying it does not intend to take enforcement action against licensed pharmacies compounding certain peptides in certain forms. According to law-firm summaries, that includes KPV in topical and oral forms. This is not FDA approval, and FDA has not added KPV to its official list.1314 As of November 13, 2026, a final policy had not been published. Check the Federal Register notice for updates.13

Safety considerations

  • Injected GHK-Cu. FDA says injected GHK-Cu may trigger immune reactions because of clumping and impurities, and that human safety data are limited.15
  • LL-37. FDA notes animal findings of possible harm to male fertility and possible tumor-promoting effects in some tissues.15
  • KPV. FDA found no animal toxicity studies and no human safety data.7
  • Melanotan II. Doctors have reported new or changing moles in people who used it.16 FDA’s safety list cites case reports of melanoma and other serious events.15 Any new or changing mole should be checked by a doctor.
  • Skin darkening. Bremelanotide (PT-141), a related peptide, can cause dark patches on the face or gums that may not fade.17
  • “Research” products are not made for human use. See our guide to research-chemical peptide risks.

Questions to ask a provider

  • Is this a cosmetic cream or a drug, and how is it regulated?
  • What human evidence supports this product for my skin or hair concern?
  • If it is an injection, has that form been tested in people? Which pharmacy makes it?
  • What side effects, including skin darkening or irritation, should I watch for?
  • What options with stronger evidence should I consider first?
  • What is the total cost, and what does it include?

Our guide on how to vet a peptide clinic can help you spot red flags.

Footnotes

  1. Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987. https://doi.org/10.3390/ijms19071987 ↩ ↩2

  2. Miller TR, Wagner JD, Baack BR, et al. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. Arch Facial Plast Surg. 2006;8(4):252-259. https://doi.org/10.1001/archfaci.8.4.252 ↩ ↩2

  3. Mulder GD, Patt LM, Sanders L, et al. Enhanced healing of ulcers in patients with diabetes by topical treatment with glycyl-l-histidyl-l-lysine copper. Wound Repair Regen. 1994;2(4):259-269. https://doi.org/10.1046/j.1524-475X.1994.20406.x ↩

  4. The Pharma Letter. ProCyte’s lead product “no better than placebo.” October 24, 1994. https://www.thepharmaletter.com/procyte-s-lead-product-no-better-than-placebo ↩

  5. Grönberg A, Mahlapuu M, Ståhle M, et al. Treatment with LL-37 is safe and effective in enhancing healing of hard-to-heal venous leg ulcers: a randomized, placebo-controlled clinical trial. Wound Repair Regen. 2014;22(5):613-621. https://doi.org/10.1111/wrr.12211 ↩

  6. Mahlapuu M, Sidorowicz A, Mikosinski J, et al. Evaluation of LL-37 in healing of hard-to-heal venous leg ulcers: a multicentric prospective randomized placebo-controlled clinical trial. Wound Repair Regen. 2021;29(6):938-950. https://doi.org/10.1111/wrr.12977 ↩

  7. U.S. Food and Drug Administration. FDA briefing document, Pharmacy Compounding Advisory Committee meeting July 23-24, 2026: KPV-related bulk drug substances. 2026. https://www.fda.gov/media/193346/download ↩ ↩2

  8. U.S. Food and Drug Administration. Notice of opportunity for hearing, proposal to debar: Edward Manookian (Melanocorp). 2016. https://www.fda.gov/regulatory-information/electronic-reading-room/notice-opportunity-hearing-nooh-manookian-edward-8516 ↩

  9. Mathew B, Mattingly A, Rupp T, et al. Evaluation of TB-500-related bulk drug substances for inclusion on the 503A Bulk Drug Substances List. U.S. Food and Drug Administration. 2026. https://www.fda.gov/media/193349/download ↩

  10. Najafi N, Maatouk H, Vardanyan KG, et al. A systematic review of the mechanisms and therapeutic applications of GHK-Cu (glycyl-L-histidyl-L-lysine-copper complex) in topical microneedle delivery: a case for expanded clinical trials. Arch Intern Med Res. 2026;9(3):269-293. https://doi.org/10.26502/aimr.0255 ↩

  11. Yamasaki K, Di Nardo A, Bardan A, et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med. 2007;13(8):975-980. https://doi.org/10.1038/nm1616 ↩

  12. Jacobus N. FDA panel votes to loosen restrictions for four peptides. PharmExec. July 24, 2026. https://www.pharmexec.com/view/fda-votes-loosen-restrictions-four-peptides ↩

  13. U.S. Department of Health and Human Services. Enforcement discretion policy regarding 503A compounding using certain peptide bulk drug substances (notice of availability). Fed Regist. 2026;91(209):68526-68527. https://www.federalregister.gov/documents/2026/10/30/2026-22192/enforcement-discretion-policy-regarding-503a-compounding-using-certain-peptide-bulk-drug-substances ↩ ↩2

  14. Sklamberg H, Kumar D, Trentacost E. HHS announces draft enforcement discretion policy paving way for pharmacies. Arnold & Porter. November 2, 2026. https://www.arnoldporter.com/en/perspectives/advisories/2026/11/hhs-announces-draft-enforcement-discretion-policy-paving-way-for-pharmacies ↩

  15. U.S. Food and Drug Administration. Certain bulk drug substances for use in compounding that may present significant safety risks. Content current as of April 22, 2026. Accessed November 2026. https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks ↩ ↩2 ↩3

  16. Cardones AR, Grichnik JM. Alpha-melanocyte-stimulating hormone-induced eruptive nevi. Arch Dermatol. 2009;145(4):441-444. https://doi.org/10.1001/archdermatol.2008.623 ↩

  17. Cosette Pharmaceuticals. VYLEESI (bremelanotide injection): prescribing information. DailyMed. 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf ↩

Frequently asked questions

What is GHK-Cu?

GHK-Cu is a small copper-binding peptide the body makes naturally. It is a common ingredient in skin creams. Human studies are few and small, and in the best-controlled one, measured skin results were no better than a regular cream.

Is a copper peptide serum the same as a GHK-Cu injection?

No. Creams are sold as cosmetics. No human studies have tested GHK-Cu injections, and FDA has raised concerns about immune reactions and impurities in injected GHK-Cu.

Can GHK-Cu regrow hair?

GHK-Cu is used in hair products, but the research behind this site did not find good human trials showing it regrows hair. A dermatologist can explain proven options for hair loss.

Is melanotan II a safe way to tan?

No. It has never been FDA-approved, and doctors have reported new or changing moles and melanoma in people who used it, although these reports cannot prove it caused them.

Peptides in our library

Questions? Talk to a licensed provider

See a free list of top rated clinics in Lakeland and Polk County, with their phone numbers and Google reviews. No one will call you.

Find a top rated provider
Find a top rated provider today